ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,363, issued on Nov. 18, was assigned to BIOMOLECULAR HOLDINGS LLC.
"NK/monocyte engagers" was invented by Daniel J. Capon (Hillsborough, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides a tetrahedral antibody comprising a first domain, a second domain, a third domain, a fourth, a fifth domain, and a sixth domain, wherein the first domain and the second domain are each a Fc domain of an IgG antibody, wherein the third domain and the fourth domain are each a Fab domain of an anti-CD20 antibody wherein the fifth domain and the sixth domain are each a Fab domain of an anti-CD-19 antibody. This invention also provides methods...